Drug Shortage Report for TEVA-FUROSEMIDE

Last updated on 2020-04-23 History
Report ID 112382
Drug Identification Number 00337749
Brand name TEVA-FUROSEMIDE
Common or Proper name FUROSEMIDE 40MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1000
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-15
Estimated end date 2020-05-31
Actual end date 2020-04-22
Shortage status Resolved
Updated date 2020-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-04-23 French Compare
v3 2020-04-23 English Compare
v2 2020-04-16 French Compare
v1 2020-04-16 English Compare

Showing 1 to 4 of 4